Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4449240
Max Phase: Preclinical
Molecular Formula: C37H62N6O8
Molecular Weight: 718.94
Molecule Type: Unknown
Associated Items:
ID: ALA4449240
Max Phase: Preclinical
Molecular Formula: C37H62N6O8
Molecular Weight: 718.94
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCN(CC)CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)N[C@@H](CO)C(=O)OC
Standard InChI: InChI=1S/C37H62N6O8/c1-11-43(12-2)20-14-13-15-28(34(48)42-30(22-44)36(50)51-10)40-35(49)29(21-23(3)4)41-32(46)25(6)38-31(45)24(5)39-33(47)26-16-18-27(19-17-26)37(7,8)9/h16-19,23-25,28-30,44H,11-15,20-22H2,1-10H3,(H,38,45)(H,39,47)(H,40,49)(H,41,46)(H,42,48)/t24-,25-,28-,29-,30-/m0/s1
Standard InChI Key: SQWGTAUPVFPVAQ-NDOOMZCZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 718.94 | Molecular Weight (Monoisotopic): 718.4629 | AlogP: 1.79 | #Rotatable Bonds: 21 |
Polar Surface Area: 195.27 | Molecular Species: BASE | HBA: 9 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.70 | CX Basic pKa: 10.30 | CX LogP: 2.08 | CX LogD: -0.58 |
Aromatic Rings: 1 | Heavy Atoms: 51 | QED Weighted: 0.08 | Np Likeness Score: -0.37 |
1. Xiong Y, Greschik H, Johansson C, Seifert L, Bacher J, Park KS, Babault N, Martini M, Fagan V, Li F, Chau I, Christott T, Dilworth D, Barsyte-Lovejoy D, Vedadi M, Arrowsmith CH, Brennan P, Fedorov O, Jung M, Farnie G, Liu J, Oppermann U, Schüle R, Jin J.. (2019) Discovery of a Potent and Selective Fragment-like Inhibitor of Methyllysine Reader Protein Spindlin 1 (SPIN1)., 62 (20): [PMID:31260300] [10.1021/acs.jmedchem.9b00522] |
Source(1):